Jump to content

p-fizer covid vaccine 💹


Yaman02

Recommended Posts

HEALTH AND SCIENCE

Pfizer stock jumps after it reports positive data in early-stage coronavirus vaccine trial

 

  • Pfizer shares jumped after it released positive results from its closely watched early-stage human trial on a coronavirus vaccine. 
  • The trial evaluated 45 people. Each participant received 10, 30 or 100 microgram doses of the vaccine or a placebo. 
  • Pfizer said the vaccine was generally well-tolerated, though the experimental vaccine also caused fever in some patients, especially for those who were in the 100 microgram group.
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...